Maxim is Managing Partner at RMI Partners. RMI Partners is a global venture capital company established in 2012, with a strategic focus on investments supporting the development of innovative biopharmaceutical products and medical technologies. Maxim plays a key part in managing venture investment portfolio. He is also a member of the Board of Directors of RMI’s public and private portfolio companies: Neothetics, Inc. (NSX:NEOT), Miramar Labs, Inc. (OTCQB:MRLB), Celtaxsys, Inc. and Atlas Genetics Ltd.
Maxim has a MBA degree from Vlerick Business School and also holds two other master degrees: in applied mathematics from Lomonosov Moscow State University and in finance from the Financial University under the Government of the Russian Federation. He is a member of the Russian Association of Independent Directors.
